Artemisia extracts, particularly from Artemisia vulgaris, have gained attention for their potential therapeutic role in CML through direct effects on BCR-ABL signaling and related pathways. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.